Mednax Inc News and Headlines -

GuruFocus Articles Total 23
  • 1
  • 2

The stock of Mednax (NYSE:MD, 30-year Financials) is believed to be modestly undervalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its

0 Views    GF Value    2021-04-11 04:12
They have underperformed the market

Mednax Inc/ (MD) and Loma Negra Compania Industrial Argentina Sociedad Anonima (LOMA) have disappointed their shareholders, underperforming the market by large margins over the past several years and never paying any dividends.

Moreover, analysts on Wall Street have issued moderate sell recommendation ratings for these stocks.


Shares of Mednax have tumbled 21% so far this year, 35.4% over the last 52 weeks and 60.5% over the last five years through Friday. The company has underperformed the S&P 500 by 45.4%, 48% and 117%.

Mednax does not pay a dividend.

The Sunrise, Florida-based provider of pediatric subspecialty physician services closed

79 Views    Alberto Abaterusso    2019-12-02 16:14
Guru's largest sales of the 2nd quarter

Richard Pzena (Trades, Portfolio), founder and chief investment officer of Pzena Investment Management, sold shares of the following stocks in the second quarter.

The guru trimmed his Franklin Resources Inc. (BEN) holding by 75.34%. The trade had an impact of -1.18% on the portfolio.


The investment firm has a market cap of $13.79 billion and an enterprise value of $9.41 billion.

GuruFocus gives the company a profitability and growth rating of 4 out of 10. The return on equity of 14.02% and return on assets of 9.59% are outperforming 68% of

69 Views    Tiziano Frateschi    2019-08-19 18:40
CVS Health Corp, Walgreens Boots Alliance Inc., Mednax Inc. and Amdocs Ltd. have declined to their respective three-year lows

CVS Health Corp. (CVS), Walgreens Boots Alliance Inc. (WBA), Mednax Inc. (MD), and Amdocs Ltd. (DOX) have declined to their three-year lows.

CVS Health Corp. (CVS) declined to $54.06

The prices of CVS Health Corp. (CVS) shares have declined to $54.06 on April 5, which is only 4.2% above the 3-year low of $51.77.

CVS Health Corp. is an American retail pharmacy and health care company that grew from the parent company Mark Steven Inc. The business began as a chain of health and beauty aid stores but within several years pharmacies were added. The company owns several subsidiaries, including

48 Views    Shuda Xia    2019-04-08 01:40
UBS Group, AutoNation, Mednax and Amdocs decline to multiyear lows

UBS Group AG (UBS), AutoNation Inc. (AN), Mednax Inc. (MD) and Amdocs Ltd. (DOX) have declined to three-year lows.

UBS Group declined to $11.88

The price of UBS Group shares declined to $11.88 on March 22, which is only 2.3% above the three-year low of $11.61.

UBS is a Swiss investment bank and financial services company. It is known for its strict bank-client confidentiality and culture of banking secrecy.

The company has a market cap of $46.05 billion; its shares were traded around $11.88 with a price-earninigs ratio of 10.44 and a price-sales ratio of 1.54. The trailing 12-month dividend

96 Views    Shuda Xia    2019-03-22 22:25
Mednax, Eaton Vance on the list

According to the GuruFocus All-In-One Screener, the following companies have grown their book value per share (BV/S) over the last decade.

BV/S is calculated as total equity minus preferred stock, divided by shares outstanding. Theoretically, it is what shareholders will receive if a company is liquidated. Total equity is a balance sheet item and equal to total assets minus total liabilities. Since the BV/S may not reflect the company’s true value, some investors check the tangible book value to confirm their investment ideas.

The BV/S of Multi-Color Corp. (LABL) has grown 12% over the last 10 years. The price-book

118 Views    Tiziano Frateschi    2018-12-19 21:35
Hawaiian Holdings tops the list

According to the GuruFocus All-In-One Screener, the following companies have grown their book value per share (BV/S) over the last decade.

BV/S is calculated as total equity minus preferred stock, divided by shares outstanding. Theoretically, it is what shareholders will receive if a company is liquidated. Total equity is a balance sheet item and equal to total assets minus total liabilities. Since the BV/S may not reflect the company’s true value, some investors check the tangible book value to confirm their investment ideas.

The BV/S of Hawaiian Holdings Inc. (HA) has grown 23% over the last 10 years. The

187 Views    Tiziano Frateschi    2018-12-05 21:02
Goldman Sachs upgraded Johnson & Johnson and downgraded Perrigo. Morgan Stanley has an 'Overweight' rating on Humana. AbbVie started with a 'Hold' rating at Berenberg

Analysts have made adjustments to their ratings on several healthcare stocks.

Berenberg has initiated coverage of AbbVie (ABBV) with a ‘Hold’ rating. The analyst established a price target of $105 per share, which represents a 10% upside.

The stock in AbbVie climbed 31% during 52 weeks of trading. It is trading below the 200, 100 and 50-SMA lines.

The 52-week range is $69.38 to $125.86 per share. The stock has a market capitalization of $144.76 billion, a price-book ratio of 42.7 times, a price-sales ratio of 4.89 times and a price-earnings of 24.04 times.

The share

65 Views    Alberto Abaterusso    2018-07-13 14:10
Companies are trading below Peter Lynch value

Companies in the health care space were dealt a huge blow on Thursday after Inc. (AMZN) announced it is acquiring online pharmacy startup PillPack.

As the e-commerce giant becomes more aggressive in its pursuit of dominating the health care sector, several companies offer good value based on their Peter Lynch values.

Lynch, who developed this method as a way to simplify his investment process, compares the price of a stock over time against the company’s earnings. He set the standard for this analysis at a price-earnings ratio of 15 as he believes mature, stable companies are worth 15

1746 Views    Sydnee Gatewood    2018-06-29 16:27
A look at warning signs and investing strategies from Peter Lynch and Warren Buffett

The Peter Lynch Growth screener listed four companies with high business predictability and at least two more positive investing signs than severe warning signs: Allegiant Travel Co. (ALGT), Big Lots Inc. (BIG), Mednax Inc. (MD) and Amerco Inc. (UHAL).

Brief overview of Peter Lynch Charts and Warning Signs features

GuruFocus provides two key features for each company: the Peter Lynch Chart and the warning signs. The former compares a company’s historical price trend to the Peter Lynch earnings line, which assumes a price-earnings ratio of 15. Figure 1 shows a sample Peter Lynch chart for Apple

1276 Views    James Li    2018-06-27 20:06
Activist investor discloses 4th-quarter portfolio

Elliott Management leader Paul Singer (Trades, Portfolio) released his portfolio for the final quarter of 2017 last week, listing eight new holdings.

The well-known activist investor typically takes large stakes in underperforming companies and then pushes management to implement changes that will turn them toward profitability. Singer’s top five new buys for the quarter are Mednax Inc. (MD), Akamai Technologies Inc. (AKAM), Uniti Group Inc. (UNIT), Convergys Corp. (CVG) and QEP Resources Inc. (QEP).


Singer invested in 2.47 million shares of Mednax for an average price of $47.14 per share, giving it 0.83% portfolio space.


865 Views    Sydnee Gatewood    2018-02-20 19:08
Guru reports quarterly portfolio

Pzena Investment Management leader Richard Pzena (Trades, Portfolio) released his fourth-quarter portfolio last week, disclosing he opened nine new positions.

According to the firm’s website, Pzena and his team use a classic value approach to invest in good businesses that are currently underperforming their historical earnings power. The current portfolio of 156 stocks is largely made up of securities in the financial services sector.

The guru’s top five buys for the quarter were Mednax Inc. (MD), Steelcase Inc. (SCS), China Mobile Ltd. (CHL), Biogen Inc. (BIIB) and Celgene Corp. (CELG).


Pzena invested in 962,030 shares

261 Views    Sydnee Gatewood    2018-02-12 17:40
These companies have grown their book values over the past decade

The following companies have grown their book values per share (BV/S) over the last 10 years.

BV/S is calculated as total equity minus preferred stock, divided by shares outstanding (EOP). Theoretically, it is what shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets minus total liabilities. Since the BV/S may not reflect the company’s true value, some investors check the tangible book value to confirm their investment ideas.

The BV/S of Gildan Activewear Inc. (GIL) has grown 18% over the past 10 years. The price-book (P/B) ratio is 3.1,

416 Views    Tiziano Frateschi    2017-09-28 18:52
Cracker Barrel, Molina Healthcare among companies increasing profitability

Companies growing their earnings per share (EPS) are often good investments as they can return a solid profit to investors. According to the discount cash flow (DCF) calculator, the following are undervalued companies that have grown EPS over a five-year period.

Cracker Barrel Old Country Store Inc.'s (CBRL) EPS grew 15% per year over the last five years.


According to the DCF calculator, the stock is undervalued and trading with a margin of safety of 4.3% at $147.73. The price-earnings (P/E) ratio is 17.63; the stock price has been as high as $175.04 and

560 Views    Tiziano Frateschi    2017-09-27 16:05
Mednax Inc., OPKO Health Inc., Terra Nitrogen Co. and Dean Foods Co. have declined to their respective three-year lows

Mednax Inc. (MD), OPKO Health Inc. (OPK), Terra Nitrogen Co. LP (TNH) and Dean Foods Co. (DF) have declined to their three-year lows.

Mednax Inc. (MD) declined to $42.90

The prices of Mednax Inc. (MD) shares have declined to $42.90 on Sept. 15, which is only 4.0% above the three-year low of $41.20.

Mednax Inc. is an American specialized health services company that focuses on neonatal, anesthesia, and pediatric physician subspecialty services in all 50 U.S. States and Puerto Rico. The company is the largest provider of newborn hearing screening in the U.S.

Mednax Inc. has a market cap of

147 Views    Shuda Xia    2017-09-16 20:52
These companies have maintained a 5-star predictability rank for the past 5 years

Among U.S. companies, six have maintained a GuruFocus Business Predictability Rank of five stars year over year since June 2012: Jack Henry & Associates Inc. (JKHY), Mednax Inc. (MD), Mesa Laboratories Inc. (MLAB), Rollins Inc. (ROL), Tyler Technologies Inc. (TYL) and World Acceptance Corp. (WRLD).

Brief introduction of Predictability Rank

GuruFocus ranks a company’s business predictability by looking at the historical trend of revenue per share and the EBITDA per share for the past 10 years. Companies that had operating loss in the past decade get a flat one-star predictability rank. Otherwise, the company’s predictability rank ranges from two

3608 Views    James Li    2017-06-02 21:11
Can they maintain their momentum into 2016?

Below is a list of five companies we purchased in 2015 that gave us great returns and are of tremendous educational value. Be aware, however, that just because we made investments in them in 2015 and they met our value screens, does not mean we would, or even could, invest in them today. We bought when the prices were right, economic fundamentals were strong, and their margins-of-safety were sufficient to qualify for investment. Also keep in mind that for a few of these positons, the market was unjustifiably pessimistic about their future growth prospects – making them very hard to

1382 Views    Daniel Seens    2016-01-03 18:04
Recent insider sales include Mednax Inc. and Super Micro Computer Inc.

According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Mednax Inc, Super Micro Computer Inc, Starz, Microsemi Corp.

Mednax Inc (MD): CEO Roger Md Medel sold 100,000 Shares

CEO of Mednax Inc (MD) Roger Md Medel sold 100,000 shares on Aug. 27 at an average price of $80.27. Mednax Inc was incorporated in Florida in 2007 and is the successor to Pediatrix Medical Group, Inc. Mednax Inc has a market cap of $7.58 billion; its shares were traded at around $79.21 with a P/E ratio of 23.49 and P/S ratio of 2.96. Mednax

704 Views    alicet236    2015-09-07 04:51

MEDNAX Inc. -- Only 10% Growth Last Weel?!

Company Overview

MEDNAX Inc. (MD) was founded in 2007, successor to Pediatric Medical Group Inc. which was incorporated in 1979, and is a leading physician services company providing newborn, anesthesia, maternal-fetal and other pediatric subspecialty care. The company is a significant $2.2 billion player in a moderately growing industry. As of December 31, 2013, MD's national network comprised:

  • Over 2,300 affiliated physicians, including approximately 1,050 physicians who provide neonatal clinical care, in 34 states and Puerto Rico, primarily within hospital-based neonatal intensive care units, to babies born prematurely or with medical complications;
603 Views    Daniel Seens    2014-11-02 19:24

According to the GuruFocus Value Screen that shows value strategies of stocks traded at historical low P/B ratios, Activision Blizzard Inc. (ATVI), Mednax Inc. (MD) and China Mobile Ltd. (CHL) are held by fairly large groups of gurus and are traded at or near their 10-year historical low P/B ratios. Here are the company updates and a few trade highlights as of the third quarter of 2013.

Activision Blizzard Inc. (ATVI)

Up 66% over 12 months, Activision Blizzard Inc. (ATVI) is traded at P/B ratio of 1.00, close to 10-year low of 0.96.First incorporated in 1979, Activision Blizzard Inc.

1040 Views    Sally Jones    2013-12-20 23:06

Headlines Total 116
  • 1
  • 2

2021-05-07 $ 32.1 (19.96%)
2021-05-06 $ 26.76 (-0.52%)
2021-04-30 $ 26.32 (-2.19%)
2021-03-23 $ 26.59 (-1.59%)
2021-03-17 $ 27.5 (1.14%)
2021-03-16 $ 27.19 (-3.62%)
2021-03-11 $ 28.05 (-1.34%)
2021-02-19 $ 22 (5.67%)
2021-02-18 $ 20.82 (-24.73%)
2021-01-15 $ 23.6 (-1.3%)
2020-12-24 $ 23.89 (-1.73%)
2020-11-09 $ 18.43 (11.7%)
2020-11-06 $ 16.5 (17.52%)
2020-10-30 $ 12.75 (-1.39%)
2020-09-21 $ 17.39 (-4.19%)
2020-09-11 $ 18.1 (-4.13%)
2020-08-17 $ 19.46 (-2.31%)
2020-07-31 $ 19.98 (-2.01%)
2020-07-30 $ 20.39 (0.74%)
2020-07-23 $ 19.55 (2.89%)
2020-07-15 $ 18.73 (3.88%)
2020-07-13 $ 18.32 (3.8%)
2020-06-26 $ 16.24 (-7.25%)
2020-06-12 $ 16.57 (1.28%)
2020-06-11 $ 16.36 (-9.21%)
2020-06-08 $ 19.95 (3.96%)
2020-05-29 $ 15.53 (-2.69%)
2020-05-27 $ 16.63 (4.72%)
2020-05-26 $ 15.88 (4.68%)
2020-05-20 $ 15.38 (4.2%)
2020-05-13 $ 13.58 (-1.16%)
2020-05-11 $ 14.12 (-3.42%)
2020-05-08 $ 14.62 (11.6%)
2020-05-07 $ 13.1 (-5.35%)
2020-04-30 $ 14.52 (0.07%)
2020-04-22 $ 11.04 (1.47%)
2020-04-21 $ 10.88 (-12.26%)
2020-04-16 $ 11.8 (-4.92%)
2020-04-14 $ 12.87 (2.63%)
2020-04-13 $ 12.54 (-10.43%)
2020-04-08 $ 13.97 (16.9%)
2020-04-07 $ 11.95 (9.63%)
2020-04-06 $ 10.9 (12.14%)
2020-04-03 $ 9.72 (-6.99%)
2020-03-26 $ 12 (-0.08%)
2020-03-17 $ 10.14 (-9.46%)
2020-03-03 $ 16.71 (-4.08%)
2020-02-24 $ 18.75 (-6.2%)
2019-12-02 $ 26.05 (-0.27%)
2019-09-27 $ 22.35 (-0.22%)
2019-07-31 $ 24.57 (-0.04%)
2019-04-24 $ 27.28 (3.45%)
2018-11-12 $ 40.1 (-1.16%)
2018-09-05 $ 48.13 (1.65%)
2018-08-31 $ 47.35 (1.18%)
2018-08-25 $ 46.96 (0.28%)
2018-08-23 $ 46.83 (-1.27%)
2018-08-20 $ 46.77 (0.04%)
2018-08-18 $ 46.75 (-0.72%)
2018-08-16 $ 46.96 (-2.45%)
2018-08-09 $ 47.6 (0.51%)
2018-08-06 $ 48.01 (1.65%)
2018-08-02 $ 45.12 (5.2%)
2018-08-01 $ 42.89 (0.23%)
2018-07-24 $ 43.29 (-0.37%)
2018-07-20 $ 43.78 (0.83%)
2018-07-19 $ 43.42 (-1.45%)
2018-02-20 $ 56.43 (-0.32%)
2018-02-12 $ 54.39 (0.83%)
2012-01-19 $ 34.71 (0.61%)
2011-10-18 $ 31.53 (-0.35%)
2010-12-10 $ 32.43 (1.03%)
2010-12-03 $ 32.08 (-0.09%)
2010-11-05 $ 30.24 (-0.49%)
2010-11-03 $ 30.67 (2.92%)
2010-08-03 $ 25.11 (6.17%)
2010-06-03 $ 29.15 (2.24%)
2010-05-17 $ 29.4 (0.89%)
Total 116
  • 1
  • 2